Kishi, Taro http://orcid.org/0000-0002-9237-2236
Sakuma, Kenji
Hatano, Masakazu
Okuya, Makoto
Matsuda, Yuki
Kato, Masaki http://orcid.org/0000-0001-6727-7272
Iwata, Nakao http://orcid.org/0000-0003-3189-6076
Funding for this research was provided by:
Grant-in-Aid for Young Scientists
Article History
Received: 13 September 2022
Revised: 12 November 2022
Accepted: 12 December 2022
First Online: 23 December 2022
Competing interests
: The authors have no conflicts of interest to declare regarding the subject of this study. Interests from the past 3 years are as follows. TK received speaker’s honoraria from Sumitomo, Eisai, Takeda, Janssen, Otsuka, Meiji, Viatris, MSD, and Mitsubishi Tanabe; a Grant-in-Aid for Scientific Research; and a research grant from the Japanese Ministry of Health, Labour and Welfare, the Japan Agency for Medical Research and Development, and Fujita Health University School of Medicine. KS received speaker’s honoraria from Sumitomo, Eisai, Kissei, Meiji, and Otsuka; a Grant-in-Aid for Young Scientists and a Research Grant for Early-Career Scientists from Fujita Health University School of Medicine; and a research grant from the Japan Agency for Medical Research and Development. MH received speaker’s honoraria from Sumitomo, Janssen, Kyowa, Otsuka, Tanabe-Mitsubishi, and Yoshitomi. MO received speaker’s honoraria from Sumitomo, Eisai, Kissei, Meiji, and Otsuka; a Grant-in-Aid for Young Scientists (21K15738), and a Research Grant for Early-Career Scientists from Fujita Health University School of Medicine. YM received speaker’s honoraria from Sumitomo, Janssen, Kyowa, Otsuka, and Mitsubishi Tanabe, and a research grant from the Japan Agency for Medical Research and Development. MK received speaker’s honoraria from Sumitomo, Otsuka, Meiji, Eli Lilly, MSD, Pfizer, Janssen, Mitsubishi Tanabe, Takeda, Lundbeck, Viatris, Eisai, Kyowa, and Ono; and a research grant from the Ministry of Health, Labor, and Welfare of Japan, the Japan Society for the Promotion of Science, SENSHIN Medical Research Foundation, the Japan Agency for Medical Research and Development, and the Japan Research Foundation for Clinical Pharmacology. He is also a consultant and/or advisory board member for Sumitomo, Otsuka, Lundbeck, Takeda, and Shionogi. NI received speaker’s honoraria from Sumitomo, Eisai, Takeda, Eli Lilly, Viatris, Janssen, Otsuka, Meiji, Shionogi, and Mitsubishi Tanabe and research grants from Eisai, Takeda, Sumitomo, and Otsuka.